Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Chevron Co. stock logo
CVX
Chevron
$165.27
+1.0%
$156.35
$139.62
$171.70
$303.79B1.127.01 million shs9.69 million shs
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$146.82
-1.2%
$155.47
$143.13
$175.97
$357.93B0.537.66 million shs7.59 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$25.26
-3.8%
$27.01
$25.23
$40.37
$148.75B0.6133.76 million shs47.04 million shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Chevron Co. stock logo
CVX
Chevron
+0.97%+4.94%+6.41%+10.81%-0.43%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
-1.15%+0.74%-5.75%-7.96%-9.72%
Pfizer Inc. stock logo
PFE
Pfizer
-3.81%-0.49%-8.45%-8.03%-34.61%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Chevron Co. stock logo
CVX
Chevron
4.8103 of 5 stars
3.42.05.00.02.52.53.1
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
4.933 of 5 stars
3.23.04.23.93.62.51.9
Pfizer Inc. stock logo
PFE
Pfizer
4.9774 of 5 stars
3.23.04.24.83.11.73.1

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Chevron Co. stock logo
CVX
Chevron
2.74
Moderate Buy$184.7511.79% Upside
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
2.46
Hold$175.8619.78% Upside
Pfizer Inc. stock logo
PFE
Pfizer
2.38
Hold$36.3343.84% Upside

Current Analyst Ratings

Latest CVX, PFE, and JNJ Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/18/2024
Chevron Co. stock logo
CVX
Chevron
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$180.00 ➝ $204.00
4/18/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$169.00 ➝ $170.00
4/17/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$168.00 ➝ $167.00
4/17/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$180.00 ➝ $170.00
4/17/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$181.00 ➝ $175.00
4/15/2024
Chevron Co. stock logo
CVX
Chevron
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$170.00 ➝ $174.00
4/15/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$215.00
4/15/2024
Pfizer Inc. stock logo
PFE
Pfizer
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$45.00
4/11/2024
Chevron Co. stock logo
CVX
Chevron
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeSector Perform ➝ Sector Outperform$170.00 ➝ $195.00
4/10/2024
Chevron Co. stock logo
CVX
Chevron
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$203.00
4/9/2024
Chevron Co. stock logo
CVX
Chevron
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$185.00 ➝ $197.00
(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Chevron Co. stock logo
CVX
Chevron
$200.95B1.53$22.49 per share7.35$85.78 per share1.93
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$85.16B4.15$13.51 per share10.87$28.57 per share5.14
Pfizer Inc. stock logo
PFE
Pfizer
$58.50B2.45$2.86 per share8.83$15.81 per share1.60

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Chevron Co. stock logo
CVX
Chevron
$21.37B$11.3614.5510.552.4110.63%15.24%9.56%4/26/2024 (Confirmed)
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$35.15B$16.049.1513.432.4545.26%36.43%15.01%7/18/2024 (Estimated)
Pfizer Inc. stock logo
PFE
Pfizer
$2.12B$0.3670.179.121.183.62%10.88%4.91%5/1/2024 (Confirmed)

Latest CVX, PFE, and JNJ Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/1/2024N/A
Pfizer Inc. stock logo
PFE
Pfizer
$0.57N/A-$0.57N/AN/AN/A  
4/26/2024Q1 24
Chevron Co. stock logo
CVX
Chevron
$3.06$2.93-$0.13N/A$48.42 billion$48.72 billion  
4/16/2024Q1 24
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.64$2.71+$0.07$3.22$21.39 billion$21.38 billion    
2/2/202412/31/2023
Chevron Co. stock logo
CVX
Chevron
$3.19$3.45+$0.26$5.68$50.93 billion$47.18 billion    
1/30/202412/31/2023
Pfizer Inc. stock logo
PFE
Pfizer
-$0.19$0.10+$0.29$0.80$14.37 billion$14.25 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Chevron Co. stock logo
CVX
Chevron
$6.523.95%+5.39%57.39%37 Years
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$4.763.24%+5.70%29.68%63 Years
Pfizer Inc. stock logo
PFE
Pfizer
$1.686.65%+2.57%466.67%15 Years

Latest CVX, PFE, and JNJ Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/24/2024
Pfizer Inc. stock logo
PFE
Pfizer
quarterly$0.426.4%5/9/20245/10/20246/14/2024
4/16/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
quarterly$1.243.36%5/20/20245/21/20246/4/2024
2/2/2024
Chevron Co. stock logo
CVX
Chevron
Quarterly$1.634.28%2/15/20242/16/20243/11/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Chevron Co. stock logo
CVX
Chevron
0.13
1.27
1.01
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.38
1.16
0.91
Pfizer Inc. stock logo
PFE
Pfizer
0.69
0.91
0.69

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Chevron Co. stock logo
CVX
Chevron
72.42%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
69.55%
Pfizer Inc. stock logo
PFE
Pfizer
68.36%

Insider Ownership

CompanyInsider Ownership
Chevron Co. stock logo
CVX
Chevron
0.18%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.16%
Pfizer Inc. stock logo
PFE
Pfizer
0.06%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Chevron Co. stock logo
CVX
Chevron
45,6001.86 billion1.85 billionOptionable
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
131,9002.41 billion2.41 billionOptionable
Pfizer Inc. stock logo
PFE
Pfizer
88,0005.66 billion5.66 billionOptionable

CVX, PFE, and JNJ Headlines

SourceHeadline
Want $2,000 in Annual Dividends? Invest $30,000 in These 3 StocksWant $2,000 in Annual Dividends? Invest $30,000 in These 3 Stocks
fool.com - April 26 at 7:45 AM
Pfizer Gets FDA OK For Beqvez Gene Therapy for Hemophilia BPfizer Gets FDA OK For Beqvez Gene Therapy for Hemophilia B
marketwatch.com - April 26 at 7:33 AM
Pfizers Beqvez Receives FDA Approval For Treatment Of Adults With Hemophilia BPfizer's Beqvez Receives FDA Approval For Treatment Of Adults With Hemophilia B
markets.businessinsider.com - April 26 at 7:33 AM
US FDA approves Pfizers gene therapy for rare bleeding disorderUS FDA approves Pfizer's gene therapy for rare bleeding disorder
reuters.com - April 26 at 7:33 AM
U.S. FDA Approves Pfizer’s BEQVEZ™ (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for Adults with Hemophilia BU.S. FDA Approves Pfizer’s BEQVEZ™ (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for Adults with Hemophilia B
finance.yahoo.com - April 26 at 7:33 AM
Pfizer Now Rivals The Worlds Most Expensive Medicine After FDA Approves Gene TherapyPfizer Now Rivals The World's Most Expensive Medicine After FDA Approves Gene Therapy
finance.yahoo.com - April 26 at 7:33 AM
UPDATE 2-US FDA approves Pfizers gene therapy for rare bleeding disorderUPDATE 2-US FDA approves Pfizer's gene therapy for rare bleeding disorder
finance.yahoo.com - April 26 at 7:33 AM
FDA approves Pfizers first gene therapy for rare inherited bleeding disorderFDA approves Pfizer's first gene therapy for rare inherited bleeding disorder
cnbc.com - April 26 at 7:02 AM
U.S. FDA Approves Pfizers BEQVEZ™ (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for Adults with Hemophilia BU.S. FDA Approves Pfizer's BEQVEZ™ (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for Adults with Hemophilia B
businesswire.com - April 26 at 6:45 AM
Pfizer (NYSE:PFE) Trading Down 2.5%Pfizer (NYSE:PFE) Trading Down 2.5%
marketbeat.com - April 25 at 6:18 PM
Syon Capital LLC Boosts Stock Position in Pfizer Inc. (NYSE:PFE)Syon Capital LLC Boosts Stock Position in Pfizer Inc. (NYSE:PFE)
marketbeat.com - April 25 at 5:33 PM
3 Bargain Stocks Near 52-week Lows3 Bargain Stocks Near 52-week Lows
marketbeat.com - April 25 at 9:46 AM
3 Bargain Stocks Near 52-week Lows (PFE)3 Bargain Stocks Near 52-week Lows (PFE)
marketbeat.com - April 25 at 9:46 AM
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technologyGlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
reuters.com - April 25 at 9:40 AM
UPDATE 1-Ad group WPP reports 1.6% drop in first-quarter organic growthUPDATE 1-Ad group WPP reports 1.6% drop in first-quarter organic growth
finance.yahoo.com - April 25 at 8:58 AM
Pfizer declares $0.42 dividendPfizer declares $0.42 dividend
msn.com - April 24 at 8:10 PM
Pfizer Inc. (NYSE:PFE) Shares Sold by Alaska Permanent Fund CorpPfizer Inc. (NYSE:PFE) Shares Sold by Alaska Permanent Fund Corp
marketbeat.com - April 24 at 5:28 PM
Pfizer Inc. (NYSE:PFE) to Issue Quarterly Dividend of $0.42Pfizer Inc. (NYSE:PFE) to Issue Quarterly Dividend of $0.42
marketbeat.com - April 24 at 5:22 PM
Pfizer Declares Second-Quarter 2024 DividendPfizer Declares Second-Quarter 2024 Dividend
businesswire.com - April 24 at 4:37 PM
Pfizer (NYSE:PFE) Trading Down 0.5%Pfizer (NYSE:PFE) Trading Down 0.5%
marketbeat.com - April 24 at 4:22 PM
Will Healthcare ETFs Lose Momentum as Q1 Earnings Unfold?Will Healthcare ETFs Lose Momentum as Q1 Earnings Unfold?
zacks.com - April 24 at 1:06 PM
Analysts Estimate Pfizer (PFE) to Report a Decline in Earnings: What to Look Out forAnalysts Estimate Pfizer (PFE) to Report a Decline in Earnings: What to Look Out for
zacks.com - April 24 at 11:06 AM
Pfizer gets grant for treatment of cancer using engineered immune cells targeting bcmaPfizer gets grant for treatment of cancer using engineered immune cells targeting bcma
pharmaceutical-technology.com - April 24 at 10:09 AM
6 of the Highest-Yielding S&P 500 Stocks Offer Huge Passive Income6 of the Highest-Yielding S&P 500 Stocks Offer Huge Passive Income
247wallst.com - April 24 at 7:30 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Chevron logo

Chevron

NYSE:CVX
Chevron Corporation, through its subsidiaries, engages in the integrated energy and chemicals operations in the United States and internationally. The company operates in two segments, Upstream and Downstream. The Upstream segment is involved in the exploration, development, production, and transportation of crude oil and natural gas; processing, liquefaction, transportation, and regasification of liquefied natural gas; transportation of crude oil through pipelines; transportation, storage, and marketing of natural gas; and carbon capture and storage, as well as a gas-to-liquids plant. The Downstream segment refines crude oil into petroleum products; markets crude oil, refined products, and lubricants; manufactures and markets renewable fuels, commodity petrochemicals, plastics for industrial uses, and fuel and lubricant additives; and transports crude oil and refined products by pipeline, marine vessel, motor equipment, and rail car. The company was formerly known as ChevronTexaco Corporation and changed its name to Chevron Corporation in 2005. Chevron Corporation was founded in 1879 and is headquartered in San Ramon, California.
Johnson & Johnson logo

Johnson & Johnson

NYSE:JNJ
Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. Its MedTech segment provides Interventional Solutions, including electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; and neurovascular care that treats hemorrhagic and ischemic stroke. this segment also offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics, ear, nose, and throat procedures; contact lenses under the ACUVUE Brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.
Pfizer logo

Pfizer

NYSE:PFE
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.